Thrombectomy or intravenous thrombolysis in patients with NIHSS of 5 or less?

医学 溶栓 闭塞 冲程(发动机) 随机对照试验 内科学 多元分析 心脏病学 单变量分析 前瞻性队列研究 外科 心肌梗塞 机械工程 工程类
作者
Valerio Da Ros,Jonathan Cortese,Olivier Chassin,Aymeric Rouchaud,Mariana Sarov,Jildaz Caroff,Cristian Mihalea,Silvia Minosse,Irina Taifas,Jacopo Scaggiante,Laura S. López Greco,Léon Ikka,Nidhal Ben Achour,Francesca Di Giuliano,Augustin Ozanne,Nicolas Legris,Marina Diomedi,Fabrizio Sallustio,Roberto Floris,Christian Denier,Laurent Spelle
出处
期刊:Journal of Neuroradiology [Elsevier]
卷期号:46 (4): 225-230 被引量:16
标识
DOI:10.1016/j.neurad.2019.01.089
摘要

To compare outcomes of minor stroke patients with intracranial vessel occlusions (IVO) underwent mechanical thrombectomy (MT) versus those treated with intravenous thrombolysis alone (IVT). We retrospectively reviewed two large prospective stroke databases from two European centers searching for patients admitted with minor stroke (i.e. NIHSS Score░≤░5), baseline mRS░=░0 and occlusion of the M1–M2 segment of the middle cerebral artery (MCA). Groups receiving (A) IVT alone and (B) MT+/-IVT were compared. Primary outcome measures were MT safety, successful recanalization rate (mTICI 2b-3) and NIHSS shift (discharge NIHSS minus admission NIHSS); secondary outcomes included discharge rates and excellent outcome (mRS 0-1) at 3 months. Univariate and multivariate analyses were performed. Thirty-two patients were enrolled in Group B (19░MT alone; 13 MT░+░IVT) and 24 in Group A. Successful recanalization (mTICI 2b-3) was obtained in 100% of cases in Group B vs 38% in Group A. Symptomatic hemorrhagic transformation rate did not differ between the two groups. Multivariate analysis reported MT as the only predictor of early (<░12░h) favorable NIHSS shift and lower NIHSS at discharge. Moreover, discharge at home and excellent outcome at 3-month follow-up were statistically associated with MT. MT in patients with minor strokes and intracranial vessel occlusion (IVO) is safe and can determine a rapid improvement of NIHSS Score. MT seems also associated with a higher rate of patients discharged at home after hospitalization and better clinical outcome at 3-month follow-up. Larger randomized trials are warranted to confirm these results.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
2秒前
i2stay完成签到,获得积分10
5秒前
zhang完成签到 ,获得积分10
8秒前
量子星尘发布了新的文献求助10
14秒前
maxthon完成签到,获得积分10
17秒前
好学的泷泷完成签到 ,获得积分10
20秒前
flac完成签到,获得积分10
22秒前
yk完成签到 ,获得积分10
25秒前
zhugao完成签到,获得积分10
28秒前
123完成签到 ,获得积分10
32秒前
彪壮的幻丝完成签到 ,获得积分10
33秒前
Kai完成签到 ,获得积分10
34秒前
风信子deon01完成签到,获得积分10
36秒前
化学喵完成签到 ,获得积分10
37秒前
xh完成签到 ,获得积分10
40秒前
量子星尘发布了新的文献求助10
41秒前
不可靠月亮完成签到,获得积分10
42秒前
Johnlian完成签到 ,获得积分10
45秒前
眼睛大羽毛完成签到,获得积分10
46秒前
顾矜应助LIZHEN采纳,获得10
48秒前
到底是谁还在做牛马完成签到 ,获得积分10
49秒前
GXW完成签到,获得积分10
50秒前
嘟嘟豆806完成签到 ,获得积分10
53秒前
白昼の月完成签到 ,获得积分0
56秒前
量子星尘发布了新的文献求助10
58秒前
可靠月亮完成签到,获得积分10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
开心浩阑应助科研通管家采纳,获得10
1分钟前
开心浩阑应助科研通管家采纳,获得10
1分钟前
梦月完成签到,获得积分10
1分钟前
bi完成签到 ,获得积分10
1分钟前
onevip完成签到,获得积分0
1分钟前
清脆的大开完成签到,获得积分10
1分钟前
jason完成签到 ,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
赧赧完成签到 ,获得积分10
1分钟前
Diflute完成签到 ,获得积分10
1分钟前
1分钟前
舒心的青亦完成签到 ,获得积分10
1分钟前
dalei001完成签到 ,获得积分10
1分钟前
高分求助中
Encyclopedia of Immunobiology Second Edition 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
List of 1,091 Public Pension Profiles by Region 1621
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] | NHBS Field Guides & Natural History 1500
The Victim–Offender Overlap During the Global Pandemic: A Comparative Study Across Western and Non-Western Countries 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
Brittle fracture in welded ships 1000
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5584832
求助须知:如何正确求助?哪些是违规求助? 4668720
关于积分的说明 14771649
捐赠科研通 4615679
什么是DOI,文献DOI怎么找? 2530253
邀请新用户注册赠送积分活动 1499111
关于科研通互助平台的介绍 1467575